Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 An evaluation of a new antiviral agent "virazole" against influenza virus infections.

× No keyword cloud information.

11 in total

1. Efficacy of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide against influenza virus infections in mice.

Authors: F E Durr; H F Lindh; M Forbes
Journal: Antimicrob Agents Chemother Date: 1975-05 Impact factor: 5.191

2. Double-blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers.

Authors: C R Magnussen; R G Douglas; R F Betts; F K Roth; M P Meagher
Journal: Antimicrob Agents Chemother Date: 1977-10 Impact factor: 5.191

Review 3. Ribavirin: a clinical overview.

Authors: H Fernandez; G Banks; R Smith
Journal: Eur J Epidemiol Date: 1986-03 Impact factor: 8.082

Review 4. Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.

Authors: Yinan Xiao; Hanyue Xu; Wen Guo; Yunuo Zhao; Yuling Luo; Ming Wang; Zhiyao He; Zhenyu Ding; Jiyan Liu; Lei Deng; Fushen Sha; Xuelei Ma
Journal: Mol Biomed Date: 2020-12-03

5. In vivo inhibition of respiratory syncytial virus by ribavirin.

Authors: J F Hruska; P E Morrow; S C Suffin; R G Douglas
Journal: Antimicrob Agents Chemother Date: 1982-01 Impact factor: 5.191

6. Effects of ribavirin on the development of the Friend leukemia.

Authors: U Opitz; H J Seidel; G Streissle
Journal: J Cancer Res Clin Oncol Date: 1980 Impact factor: 4.553

7. Inhibition of influenza RNA synthesis by virazole (ribavirin).

Authors: C Scholtissek
Journal: Arch Virol Date: 1976 Impact factor: 2.574

8. Comparative inhibition of influenza and parainfluenza virus replication by ribavirin in MDCK cells.

Authors: M J Browne
Journal: Antimicrob Agents Chemother Date: 1981-05 Impact factor: 5.191

9. Effects of ribavirin on respiratory syncytial virus in vitro.

Authors: J F Hruska; J M Bernstein; R G Douglas; C B Hall
Journal: Antimicrob Agents Chemother Date: 1980-05 Impact factor: 5.191

10. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs.

Authors: Emily L C Tan; Eng Eong Ooi; Chin-Yo Lin; Hwee Cheng Tan; Ai Ee Ling; Bing Lim; Lawrence W Stanton
Journal: Emerg Infect Dis Date: 2004-04 Impact factor: 6.883